| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/29/2001 | WO2001021585A2 Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents |
| 03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
| 03/29/2001 | WO2000075139A3 Benzothiazinone and benzoxazinone compounds |
| 03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
| 03/29/2001 | CA2384296A1 Therapeutic quinazoline derivatives |
| 03/29/2001 | CA2384291A1 Quinazoline derivatives and their use as pharmaceuticals |
| 03/28/2001 | EP1086950A1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |
| 03/28/2001 | EP1086179A1 Energy transfer assay method and reagent |
| 03/28/2001 | EP1086097A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 03/28/2001 | EP1086094A1 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086083A1 Protease inhibitors |
| 03/28/2001 | EP1086076A1 Sulfonamide inhibitors of aspartyl protease |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085875A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | EP0775132B1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 03/28/2001 | EP0708762B1 Process for making hiv protease inhibitors |
| 03/28/2001 | CN1289334A Benzothiadiazoles and derivatives |
| 03/28/2001 | CN1289333A Oxazole derivatives as serotonin-1A receptor ogonists |
| 03/28/2001 | CN1289326A N-[(substituted five-membered di-or thiaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia |
| 03/28/2001 | CN1289321A Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 03/28/2001 | CN1289248A Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 03/28/2001 | CN1063748C Naphthalene derivatives, process for preparation thereof and intermediates thereof |
| 03/27/2001 | US6207830 Reacting an isocyanate with an enamine in presence of a base |
| 03/27/2001 | US6207698 For therapy of osteoarthritis, rheumatoid arthritis, corneal ulceration, periodontitis, metastasis and invasion of tumor, and virus infection |
| 03/27/2001 | US6207697 Amidinyl-substituted rings; anticoagulants; thromboembolic disorders; antiischemic and antiinflammatory agents; strokes; serine protease inhibitors |
| 03/27/2001 | US6207693 Benzamide derivatives having a vasopressin antagonistic activity |
| 03/27/2001 | US6207690 Treating tumor by administering therapeutically effective amount of triglitazone compound |
| 03/27/2001 | US6207680 Heteroarylpiperidines and their use as antipsychotics and analgesics |
| 03/27/2001 | US6207677 Adminisering sigma receptor binding piperidine derivative for treating anxiety, epilepsy, convulsion, movement disorder, amnesia |
| 03/27/2001 | US6207672 Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acids |
| 03/27/2001 | US6207665 To treat inflammatory disorders in humans |
| 03/27/2001 | US6207662 Useful in the treatment of central nervous system disorders, psychotic disorders such as schizophrenia |
| 03/27/2001 | US6207618 Heterocyclic substituted 4-benzoyl-pyrazole as herbicides |
| 03/22/2001 | WO2001019822A1 Antiviral agents |
| 03/22/2001 | WO2001019821A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 03/22/2001 | WO2001019820A1 Substituted pyrazol-3-ylbenzoxazinones |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/22/2001 | WO2001019806A1 Process for the preparation of oxazole derivatives |
| 03/22/2001 | WO2001019803A1 Unsaturated oxime ethers and the use thereof for control of harmful fungi and veterinary pests |
| 03/22/2001 | WO2001019802A1 Aromatic nitrogenous six-membered ring compounds |
| 03/22/2001 | WO2000063195A8 Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | CA2384898A1 Antiviral agents |
| 03/21/2001 | EP1085018A1 Taxoid compound and method for producing the same |
| 03/21/2001 | EP1084127A1 Organometallic complex molecule and organic electroluminescent device using the same |
| 03/21/2001 | EP1084121A1 Oxadiazoline derivatives and their use as insecticides |
| 03/21/2001 | EP1084116A1 Cyclohexenondioxothio chromanoyl derivatives |
| 03/21/2001 | EP1084106A1 N-linked sulfonamides of heterocyclic carboxylic acids or carboxylic acid isosteres |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083900A2 Topical administration of oxazolidinones for transdermal delivery |
| 03/21/2001 | EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | EP0717616B1 Process for conditioning substances |
| 03/21/2001 | CN1288462A Oxazolidinone combinatorial libraries, compositions and method of prepn. |
| 03/20/2001 | US6204388 Using blocking agent |
| 03/20/2001 | US6204280 Oxazolidinone derivative, anticoagulant |
| 03/20/2001 | US6204277 Treating diabetes |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204260 Non-peptidyl vasopressin V1a antagonists |
| 03/20/2001 | US6204222 Substituted cyclohexene-1,2-dicarboxylic acid derivatives and intermediates for their preparation |
| 03/15/2001 | WO2001017994A1 Oxazole ppar antagonists |
| 03/15/2001 | WO2001017993A1 Alkylpiperidi nylbenzo [d] isoxazole derivatives having psychotropic activity, pharmaceutical compositions containing the same, and a process for the preparation of the active ingredient |
| 03/15/2001 | WO2001017985A1 Novel derivatives of flavones, xanthones and coumarins |
| 03/15/2001 | WO2001017981A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |
| 03/15/2001 | WO2001017980A1 Novel processes for preparing oxazepine derivatives |
| 03/15/2001 | WO2001017976A1 Bis-sulfonamides |
| 03/15/2001 | WO2001017975A1 Pyrimidine derivatives and herbicides containing the same |
| 03/15/2001 | WO2001017972A2 Novel herbicides |
| 03/15/2001 | WO2001017968A1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 03/15/2001 | WO2001017965A2 Cyanopiperidines as pesticides |
| 03/15/2001 | WO2001017959A2 Vitronectin receptor antagonists |
| 03/15/2001 | WO1999065870A3 Sulfonamide inhibitors of aspartyl protease |
| 03/15/2001 | CA2384671A1 Vitronectin receptor antagonists |
| 03/15/2001 | CA2383731A1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors |
| 03/14/2001 | EP1082323A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082322A2 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082321A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082313A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082312A1 Sulfonyl amino (thio)carbonyl triazoline (thi)ons having alkenyl substituents |
| 03/14/2001 | EP1082308A1 Heterocyclically substituted amides used as calpain inhibitors |
| 03/14/2001 | EP1082301A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |